Class information for:
Level 1: STREPTOKINASE//CORONARY THROMBOLYSIS//ANISTREPLASE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1755 2426 32.1 64%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
11 38152 PERCUTANEOUS CORONARY INTERVENTION//DRUG ELUTING STENT//CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 STREPTOKINASE Author keyword 16 16% 4% 94
2 CORONARY THROMBOLYSIS Author keyword 8 38% 1% 16
3 ANISTREPLASE Author keyword 5 47% 0% 8
4 PLASMINOGEN ACTIVATOR RECOMBINANT TISSUE TYPE Author keyword 4 67% 0% 4
5 MODIFIED TISSUE TYPE PLASMINOGEN ACTIVATOR Author keyword 4 75% 0% 3
6 TISSUE TYPE PLASMINOGEN ACTIVATOR T PA MODIFIED Author keyword 3 100% 0% 3
7 SARUPLASE Author keyword 3 45% 0% 5
8 REOCCLUSION Author keyword 3 20% 1% 13
9 APSAC Author keyword 2 38% 0% 5
10 CORONARY PATENCY Author keyword 2 44% 0% 4

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 STREPTOKINASE 16 16% 4% 94 Search STREPTOKINASE Search STREPTOKINASE
2 CORONARY THROMBOLYSIS 8 38% 1% 16 Search CORONARY+THROMBOLYSIS Search CORONARY+THROMBOLYSIS
3 ANISTREPLASE 5 47% 0% 8 Search ANISTREPLASE Search ANISTREPLASE
4 PLASMINOGEN ACTIVATOR RECOMBINANT TISSUE TYPE 4 67% 0% 4 Search PLASMINOGEN+ACTIVATOR++RECOMBINANT+TISSUE+TYPE Search PLASMINOGEN+ACTIVATOR++RECOMBINANT+TISSUE+TYPE
5 MODIFIED TISSUE TYPE PLASMINOGEN ACTIVATOR 4 75% 0% 3 Search MODIFIED+TISSUE+TYPE+PLASMINOGEN+ACTIVATOR Search MODIFIED+TISSUE+TYPE+PLASMINOGEN+ACTIVATOR
6 TISSUE TYPE PLASMINOGEN ACTIVATOR T PA MODIFIED 3 100% 0% 3 Search TISSUE+TYPE+PLASMINOGEN+ACTIVATOR+T+PA+MODIFIED Search TISSUE+TYPE+PLASMINOGEN+ACTIVATOR+T+PA+MODIFIED
7 SARUPLASE 3 45% 0% 5 Search SARUPLASE Search SARUPLASE
8 REOCCLUSION 3 20% 1% 13 Search REOCCLUSION Search REOCCLUSION
9 APSAC 2 38% 0% 5 Search APSAC Search APSAC
10 CORONARY PATENCY 2 44% 0% 4 Search CORONARY+PATENCY Search CORONARY+PATENCY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 INTRAVENOUS STREPTOKINASE 126 35% 12% 296
2 INTRACORONARY STREPTOKINASE 66 44% 5% 115
3 CORONARY THROMBOLYSIS 42 28% 5% 126
4 ANISOYLATED PLASMINOGEN 27 92% 0% 11
5 NEUTRALIZATION TITERS 24 82% 1% 14
6 STREPTOKINASE 22 11% 8% 198
7 ANISTREPLASE 22 55% 1% 27
8 APSAC 19 71% 1% 15
9 REOCCLUSION 17 22% 3% 68
10 TIMI TRIAL 15 38% 1% 31

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
CURRENT CONCEPTS - THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION 1993 155 40 55%
HISTORY OF DRUGS FOR THROMBOTIC DISEASE - DISCOVERY, DEVELOPMENT, AND DIRECTIONS FOR THE FUTURE 1994 60 16 56%
THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - A REVIEW 1992 104 122 78%
THROMBOLYTIC THERAPY - CURRENT STATUS .1. 1988 436 70 60%
INTRAVENOUS AND INTRACORONARY FIBRINOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION - OVERVIEW OF RESULTS ON MORTALITY, REINFARCTION AND SIDE-EFFECTS FROM 33 RANDOMIZED CONTROLLED TRIALS 1985 466 20 80%
CORONARY THROMBOLYSIS - STREPTOKINASE OR RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR 1990 72 50 96%
Intravenous thrombolysis in acute myocardial infarction 2001 28 161 43%
Comparative efficacy of thrombolytics in acute myocardial infarction: a systematic review 2003 23 21 43%
STREPTOKINASE AND RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR (RT-PA) ARE EQUALLY EFFECTIVE IN TREATING ACUTE MYOCARDIAL-INFARCTION 1991 45 56 86%
METAANALYSIS OF ALL AVAILABLE PUBLISHED CLINICAL-TRIALS (1958-1990) ON THROMBOLYTIC THERAPY FOR AMI - RELATIVE EFFICACY OF DIFFERENT THERAPEUTIC STRATEGIES 1994 11 288 84%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 KLIN KARDIOL ALLGEMEINE INNERE MED 2 40% 0.2% 4
2 THROMBOSIS HEMOSTASIS SPECIAL HEMATOL CLIN 1 33% 0.1% 2
3 MED NEW ENGLAND MED NEUROL 1 50% 0.0% 1
4 MYONG GOK EYE 1 50% 0.0% 1
5 NEW JERSEY MED HYPERTENS 1 50% 0.0% 1
6 OSPED CIVILE CARDIOL 1 50% 0.0% 1
7 PATHOL KLIN BIOCHEM 1 50% 0.0% 1
8 PLIED PHARMACOL 1 50% 0.0% 1
9 ALBANY MED BIOCHEM MOLEC BIOL 0 33% 0.0% 1
10 THORNDIKE MED 0 33% 0.0% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000160470 STAPHYLOKINASE//FIBRINOLYSIS//PLASMINOGEN
2 0.0000156374 PREHOSPITAL DELAY//PRE HOSPITAL DELAY//PREHOSPITAL DELAY TIME
3 0.0000131913 SELVESTER QRS SCORE//VECTORCARDIOGRAPHY//ST MONITORING
4 0.0000124291 DOOR TO BALLOON TIME//PRIMARY ANGIOPLASTY//STEMI
5 0.0000106468 NON Q WAVE MI//NON Q MYOCARDIAL INFARCTION//NON Q WAVE
6 0.0000098887 BRAUNWALD CLASSIFICATION//REFRACTORY UNSTABLE ANGINA//CORONARY MORPHOLOGY
7 0.0000075047 COLOR KINESIS//WALL MOTION INDEX//LEFT VENTRICULAR SHAPE
8 0.0000051309 THROMBOSIS EXPERIMENTAL//ACUTE LIMB ISCHEMIA//THROMBECTOMY
9 0.0000051145 CATHETERIZAT L2//DEGREE OF REVASCULARIZATION//DIPYRIDAMOLE MYOCARDIAL SCINTIGRAPHY
10 0.0000049763 ANTIMYOSIN ANTIBODY//TC 99M GLUCARATE//ANTIMYOSIN SCINTIGRAPHY